Metabolic Impacts of Dietary Fructose on Health

Dietary fructose, a monosaccharide prevalent in fruit, sugar-sweetened beverages and processed foods, exerts distinctive effects on human metabolism owing to its primary hepatic uptake and unique enzymatic handling. Unlike glucose, fructose bypasses the key regulatory step at phosphofructokinase, driving unregulated fructolysis and stimulating both gluconeogenesis and de novo lipogenesis. This metabolic routing underpins hepatic steatosis, hypertriglyceridaemia and dysregulated glucose homeostasis. Beyond the liver, excessive fructose intake promotes adipose tissue inflammation, oxidative stress and altered adipokine profiles, contributing to systemic insulin resistance. In skeletal muscle, fructose-induced mitochondrial dysfunction impairs oxidative capacity and amplifies reactive oxygen species (ROS) production. Collectively, these processes elevate the risk of non-alcoholic fatty liver disease, type 2 diabetes and cardiovascular complications. The global surge in fructose consumption, especially among children and adolescents, underscores the urgent need for dietary strategies that mitigate its metabolic burden and inform public health policy.

Research from Nature Portfolio

Recent studies using systematic nutritional geometry reveal that in animal models a 50:50 mix of fructose and glucose under low to moderate fat conditions is more obesogenic and metabolically adverse than either monosaccharide alone, whereas at high dietary fat loads the sugar composition becomes less influential. This work reconciles competing obesity theories by showing context-dependent roles for both carbohydrate and fat. In a complementary investigation, chronic fructose supplementation in rodents induced hepatic triglyceride deposition with distinct shifts in fatty acid profiles and selectively impaired insulin signalling in liver and adipose tissue, marked by reduced Akt phosphorylation, as well as diminished GLUT4 translocation in skeletal muscle. These findings demonstrate that fructose, independently of caloric excess, can drive organ-specific metabolic dysfunction.

Metabolic Impacts of Dietary Fructose on Health publication trend

The graph below shows the total number of articles in metabolic impacts of dietary fructose on health across all publications each year (not limited to Nature Index journals).

Technical terms

De novo lipogenesis (DNL): the metabolic conversion of excess carbohydrates into fatty acids, predominantly occurring in the liver.

Insulin resistance: a pathophysiological state in which cells exhibit reduced responsiveness to circulating insulin, impairing glucose uptake.

Hepatic steatosis: the intracellular accumulation of triglycerides in hepatocytes, often referred to as fatty liver.

Reactive oxygen species (ROS): highly reactive molecules derived from oxygen metabolism that can cause oxidative damage.

Adipokines: bioactive proteins secreted by adipose tissue that modulate energy balance, inflammation and insulin sensitivity.

References

1. Determining the metabolic effects of dietary fat, sugars and fat-sugar interaction using nutritional geometry in a dietary challenge study with male mice. Nature Communications (2023).
2. Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues. Scientific Reports (2016).
3. Age-Dependent Skeletal Muscle Mitochondrial Response to Short-Term Increased Dietary Fructose. Antioxidants (2023).
4. The Impact of Excessive Fructose Intake on Adipose Tissue and the Development of Childhood Obesity. Nutrients (2024).